Brought to you by 
Light Sciences Oncology spins out; raises $67mm in Series A
22 May 2017
Executive Summary
Photoreactive therapeutics and device company Light Sciences Corp. has spun out Light Sciences Oncology (LSO) to further develop cancer treatments. Concurrently, the new company raised $35mm in its Series A financing round.
Deal Industry
- Biotechnology
- Medical Devices
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Spin-Off
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Light Sciences Oncology spins out; raises $67mm in Series A
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice